Genetic Perspectives on Childhood Monogenic Diabetes: Diagnosis, Management, and Future Directions

Overview

Journal World J Diabetes

Publisher Baishideng Publishing Group

Specialty Endocrinology

Date 2024 Jan 15

PMID 38222792

Authors

Hong-Yan Sun

Xiao-Yan Lin

Affiliations

Soon will be listed here.

Abstract

Monogenic diabetes is caused by one or even more genetic variations, which may be uncommon yet have a significant influence and cause diabetes at an early age. Monogenic diabetes affects 1 to 5% of children, and early detection and gene-tically focused treatment of neonatal diabetes and maturity-onset diabetes of the young can significantly improve long-term health and well-being. The etiology of monogenic diabetes in childhood is primarily attributed to genetic variations affecting the regulatory genes responsible for beta-cell activity. In rare instances, mutations leading to severe insulin resistance can also result in the development of diabetes. Individuals diagnosed with specific types of monogenic diabetes, which are commonly found, can transition from insulin therapy to sulfonylureas, provided they maintain consistent regulation of their blood glucose levels. Scientists have successfully devised materials and methodologies to distinguish individuals with type 1 or 2 diabetes from those more prone to monogenic diabetes. Genetic screening with appropriate findings and interpretations is essential to establish a prognosis and to guide the choice of therapies and management of these interrelated ailments. This review aims to design a comprehensive literature summarizing genetic insights into monogenetic diabetes in children and adolescents as well as summarizing their diagnosis and mana-gement.

Citing Articles

Exploring the genetic basis of childhood monogenic diabetes.

Sanyal D World J Diabetes. 2024; 15(9):1829-1832.

PMID: 39280182 PMC: 11372639. DOI: 10.4239/wjd.v15.i9.1829.

Monogenic diabetes in children: An underdiagnosed and poorly managed clinical dilemma.

Bhattacharya S, Pappachan J World J Diabetes. 2024; 15(6):1051-1059.

PMID: 38983823 PMC: 11229976. DOI: 10.4239/wjd.v15.i6.1051.

The Importance of Molecular Genetic Testing for Precision Diagnostics, Management, and Genetic Counseling in MODY Patients.

Butnariu L, Bizim D, Oltean C, Rusu C, Panzaru M, Paduraru G Int J Mol Sci. 2024; 25(12).

PMID: 38928025 PMC: 11204182. DOI: 10.3390/ijms25126318.

References

Kim W, Bang A, Kim S, Lee G, Kim Y, Choi S . Adiponectin-targeted SERS immunoassay biosensing platform for early detection of gestational diabetes mellitus. Biosens Bioelectron. 2022; 213:114488. DOI: 10.1016/j.bios.2022.114488. View

Rafiq M, Flanagan S, Patch A, Shields B, Ellard S, Hattersley A . Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care. 2007; 31(2):204-9. PMC: 7611807. DOI: 10.2337/dc07-1785. View

Ellard S, Flanagan S, Girard C, Patch A, Harries L, Parrish A . Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects. Am J Hum Genet. 2007; 81(2):375-82. PMC: 1950816. DOI: 10.1086/519174. View

Gloyn A, Pearson E, Antcliff J, Proks P, Bruining G, Slingerland A . Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med. 2004; 350(18):1838-49. DOI: 10.1056/NEJMoa032922. View

Flanagan S, Patch A, Mackay D, Edghill E, Gloyn A, Robinson D . Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood. Diabetes. 2007; 56(7):1930-7. PMC: 7611811. DOI: 10.2337/db07-0043. View

Goto Y, Nonaka I, Horai S . A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990; 348(6302):651-3. DOI: 10.1038/348651a0. View

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2019; 43(Suppl 1):S14-S31. DOI: 10.2337/dc20-S002. View

Sanyoura M, Philipson L, Naylor R . Monogenic Diabetes in Children and Adolescents: Recognition and Treatment Options. Curr Diab Rep. 2018; 18(8):58. PMC: 6312113. DOI: 10.1007/s11892-018-1024-2. View

Ochs H, Gambineri E, Torgerson T . IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity. Immunol Res. 2007; 38(1-3):112-21. DOI: 10.1007/s12026-007-0022-2. View

10.

Njolstad P, Sovik O, Bjorkhaug L, Massa O, Barbetti F, Undlien D . Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med. 2001; 344(21):1588-92. DOI: 10.1056/NEJM200105243442104. View

11.

Ogurtsova K, Guariguata L, Barengo N, Ruiz P, Sacre J, Karuranga S . IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract. 2021; 183:109118. DOI: 10.1016/j.diabres.2021.109118. View

12.

Flanagan S, Kapoor R, Mali G, Cody D, Murphy N, Schwahn B . Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol. 2010; 162(5):987-92. PMC: 2857991. DOI: 10.1530/EJE-09-0861. View

13.

Codner E, Rocha A, Deng L, Martinez-Aguayo A, Godoy C, Mericq V . Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus. Pediatr Diabetes. 2009; 10(6):382-8. PMC: 2864306. DOI: 10.1111/j.1399-5448.2009.00499.x. View

14.

Yamagata K, Oda N, Kaisaki P, Menzel S, Furuta H, Vaxillaire M . Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 1996; 384(6608):455-8. DOI: 10.1038/384455a0. View

15.

Nasykhova Y, Barbitoff Y, Serebryakova E, Katserov D, Glotov A . Recent advances and perspectives in next generation sequencing application to the genetic research of type 2 diabetes. World J Diabetes. 2019; 10(7):376-395. PMC: 6656706. DOI: 10.4239/wjd.v10.i7.376. View

16.

Gharravi A, Jafar A, Ebrahimi M, Mahmodi A, Pourhashemi E, Haseli N . Current status of stem cell therapy, scaffolds for the treatment of diabetes mellitus. Diabetes Metab Syndr. 2018; 12(6):1133-1139. DOI: 10.1016/j.dsx.2018.06.021. View

17.

Shimomura K, Girard C, Proks P, Nazim J, Lippiat J, Cerutti F . Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects. Diabetes. 2006; 55(6):1705-12. DOI: 10.2337/db05-1640. View

18.

Senee V, Chelala C, Duchatelet S, Feng D, Blanc H, Cossec J . Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet. 2006; 38(6):682-7. DOI: 10.1038/ng1802. View

19.

Matschinsky F . Glucokinase as glucose sensor and metabolic signal generator in pancreatic beta-cells and hepatocytes. Diabetes. 1990; 39(6):647-52. DOI: 10.2337/diab.39.6.647. View

20.

Krizkova K, Veverka V, Maletinska L, Hexnerova R, Brzozowski A, Jiracek J . Structural and functional study of the GlnB22-insulin mutant responsible for maturity-onset diabetes of the young. PLoS One. 2014; 9(11):e112883. PMC: 4244080. DOI: 10.1371/journal.pone.0112883. View